Latest Breaking News On - Haimen jiangsu - Page 8 : comparemela.com

Biocytogen Announces RenLite™ Licensing Agreement with Janssen

Biocytogen Announces RenLite™ Licensing Agreement with Janssen
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

GermanyBeijingChinaBostonMassachusettsUnited statesHeidelbergBaden wübergShanghaiHaimen jiangsuYuelei shenJanssen pharmaceutical companies of johnsonPharmaceuticals beijing co ltdMerck kgaJanssen biotech incJohnson innovation

Biocytogen Announces RenLite™ Licensing Agreement with Janssen

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the signing of a nonexclusive license agreement with Janssen Biotech Inc. one of the Janssen Pharmaceutical Companies of Johnson Johnson Janssen.

ChinaGermanyBeijingBostonMassachusettsUnited statesHeidelbergBaden wübergShanghaiHaimen jiangsuYuelei shenJanssen pharmaceutical companies of johnsonMerck kgaJanssen biotech incJohnson innovationMerck kgaa

Biocytogen's Subsidiary Eucure Biopharma and Chipscreen Biosciences' Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ( Biocytogen , HKEX: 02315) today announced that its wholly owned subsidiary, Eucure (Beijing) Biopharma Co., Ltd. (“Eucure Biopharma”), has reached an exclusive licensing agreement with Chipscreen NewWay Biosciences (“Chipscreen NewWay”), a holding subsidiary of Shenzhen Chipscreen Biosciences Co., Ltd.

ChinaChengduSichuanGermanyTaiwanShanghaiUnited statesHong kongShenzhenGuangdongBostonMassachusettsBeijingHeidelbergBaden wübergMacau

Biocytogen Launches "Nano 100 Project" to Develop Fully Human Nanobody Therapeutics for Over 100 Targets

Biocytogen Launches "Nano 100 Project" to Develop Fully Human Nanobody Therapeutics for Over 100 Targets
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

GermanyBeijingChinaBostonMassachusettsUnited statesHeidelbergBaden wübergShanghaiHaimen jiangsuYuelei shenBiocytogen pharmaceuticals beijing co ltdProject integrumBiocytogen pharmaceuticals

Biocytogen Launches "Nano 100 Project" to Develop Fully Human Nanobody Therapeutics for Over 100 Targets2

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ( Biocytogen , HKEX: 02315) today announced the launch of the “Nano 100 Project”, which aims to develop fully human nanobody drugs for over 100 targets.

ChinaGermanyBeijingBostonMassachusettsUnited statesHeidelbergBaden wübergShanghaiHaimen jiangsuYuelei shenBiocytogen pharmaceuticals beijing co ltdProject integrumMedia contactBiocytogenBiocytogen pharmaceuticals